{"entity":{"type":"insider","cik":"0001253936","url":"/insider/0001253936","json_url":"/insider/0001253936.json","name":"WILDS DANIEL O","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":19,"first":"2004-05-25","last":"2008-11-19","span_basis":"filed_date"},"name_variants":[{"name":"WILDS DANIEL O","source":"filing","n_filings":19,"first_seen":"2004-05-25","last_seen":"2008-11-19"}],"transactions":[{"id":3311167,"accession":"0001181431-08-062988","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-08-062988","line_url":"/filing/0001181431-08-062988","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.904,"price_display":"0.90","price_state":"stated","total_value":4520.0,"total_display":"4,520.00","total_whole":"4,520","shares_owned_after":108800.0,"shares_owned_after_display":"108,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-19","filed_date":"2008-11-19","scope":"insider","n_lines":7},{"id":2785908,"accession":"0001181431-08-061352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-08-061352","line_url":"/filing/0001181431-08-061352#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":4450.0,"total_display":"4,450.00","total_whole":"4,450","shares_owned_after":104000.0,"shares_owned_after_display":"104,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-12","filed_date":"2008-11-13","scope":"insider"},{"id":3988927,"accession":"0001181431-08-035456","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-035456","line_url":"/filing/0001181431-08-035456","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.0432,"price_display":"1.04","price_state":"stated","total_value":2608.0,"total_display":"2,608.00","total_whole":"2,608","shares_owned_after":98200.0,"shares_owned_after_display":"98,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-30","filed_date":"2008-05-30","scope":"insider","n_lines":2},{"id":2694477,"accession":"0001181431-08-029725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-029725","line_url":"/filing/0001181431-08-029725","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.0656,"price_display":"1.07","price_state":"stated","total_value":2664.0,"total_display":"2,664.00","total_whole":"2,664","shares_owned_after":96500.0,"shares_owned_after_display":"96,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-07","filed_date":"2008-05-08","scope":"insider","n_lines":2},{"id":7114250,"accession":"0001181431-07-073585","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-07-073585","line_url":"/filing/0001181431-07-073585","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.3442,"price_display":"1.34","price_state":"stated","total_value":13442.0,"total_display":"13,442.00","total_whole":"13,442","shares_owned_after":62000.0,"shares_owned_after_display":"62,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-06","filed_date":"2007-12-06","scope":"insider","n_lines":2},{"id":7886734,"accession":"0001181431-07-032873","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-07-032873","line_url":"/filing/0001181431-07-032873","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.4104,"price_display":"2.41","price_state":"stated","total_value":12052.0,"total_display":"12,052.00","total_whole":"12,052","shares_owned_after":52000.0,"shares_owned_after_display":"52,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-16","filed_date":"2007-05-16","scope":"insider","n_lines":4},{"id":7565368,"accession":"0001181431-07-019709","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-07-019709","line_url":"/filing/0001181431-07-019709","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.2451,"price_display":"2.25","price_state":"stated","total_value":22451.0,"total_display":"22,451.00","total_whole":"22,451","shares_owned_after":47000.0,"shares_owned_after_display":"47,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-16","filed_date":"2007-03-16","scope":"insider","n_lines":3},{"id":3610250,"accession":"0001181431-06-063066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-063066","line_url":"/filing/0001181431-06-063066#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.77,"price_display":"4.77","price_state":"stated","total_value":23850.0,"total_display":"23,850.00","total_whole":"23,850","shares_owned_after":37000.0,"shares_owned_after_display":"37,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-13","filed_date":"2006-11-13","scope":"insider"},{"id":2695913,"accession":"0001181431-06-036602","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-036602","line_url":"/filing/0001181431-06-036602#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":4930.0,"total_display":"4,930.00","total_whole":"4,930","shares_owned_after":32000.0,"shares_owned_after_display":"32,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-06-13","filed_date":"2006-06-13","scope":"insider"},{"id":3743184,"accession":"0001181431-06-036323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-036323","line_url":"/filing/0001181431-06-036323#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":4.98,"price_display":"4.98","price_state":"stated","total_value":7470.0,"total_display":"7,470.00","total_whole":"7,470","shares_owned_after":31000.0,"shares_owned_after_display":"31,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-06-12","filed_date":"2006-06-12","scope":"insider"},{"id":3565968,"accession":"0001181431-06-032012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-032012","line_url":"/filing/0001181431-06-032012#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":5.04,"price_display":"5.04","price_state":"stated","total_value":12600.0,"total_display":"12,600.00","total_whole":"12,600","shares_owned_after":29500.0,"shares_owned_after_display":"29,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-19","filed_date":"2006-05-22","scope":"insider"},{"id":9247704,"accession":"0001181431-06-032114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-06-032114","line_url":"/filing/0001181431-06-032114","is_derivative":false,"issuer_cik":"0001253936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0001253936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.23999,"price_display":"5.24","price_state":"stated","total_value":26199.95,"total_display":"26,199.95","total_whole":"26,200","shares_owned_after":23000.0,"shares_owned_after_display":"23,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-16","filed_date":"2006-05-22","scope":"insider","n_lines":8},{"id":3890024,"accession":"0001181431-06-030732","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001181431-06-030732","line_url":"/filing/0001181431-06-030732","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":5.248684782608696,"price_display":"5.25","price_state":"stated","total_value":24143.95,"total_display":"24,143.95","total_whole":"24,144","shares_owned_after":25300.0,"shares_owned_after_display":"25,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-16","filed_date":"2006-05-16","scope":"insider","n_lines":7},{"id":3890011,"accession":"0001181431-06-030732","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-030732","line_url":"/filing/0001181431-06-030732#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":5.14,"price_display":"5.14","price_state":"stated","total_value":2056.0,"total_display":"2,056.00","total_whole":"2,056","shares_owned_after":22400.0,"shares_owned_after_display":"22,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-16","filed_date":"2006-05-16","scope":"insider"},{"id":1442142,"accession":"0001277422-05-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001277422-05-000004","line_url":"/filing/0001277422-05-000004","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":3.2496,"price_display":"3.25","price_state":"stated","total_value":8124.0,"total_display":"8,124.00","total_whole":"8,124","shares_owned_after":21900.0,"shares_owned_after_display":"21,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-08","filed_date":"2005-06-08","scope":"insider","n_lines":2},{"id":1673135,"accession":"0001253936-05-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253936-05-000001","line_url":"/filing/0001253936-05-000001#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.87,"price_display":"3.87","price_state":"stated","total_value":7740.0,"total_display":"7,740.00","total_whole":"7,740","shares_owned_after":19500.0,"shares_owned_after_display":"19,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-04-07","filed_date":"2005-04-08","scope":"insider"},{"id":550717,"accession":"0001253936-04-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253936-04-000006","line_url":"/filing/0001253936-04-000006#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.88,"price_display":"1.88","price_state":"stated","total_value":4700.0,"total_display":"4,700.00","total_whole":"4,700","shares_owned_after":17500.0,"shares_owned_after_display":"17,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-27","filed_date":"2004-08-27","scope":"insider"},{"id":389442,"accession":"0001253936-04-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253936-04-000003","line_url":"/filing/0001253936-04-000003#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR Pharma, Inc.","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":9100.0,"total_display":"9,100.00","total_whole":"9,100","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-18","filed_date":"2004-08-19","scope":"insider"},{"id":535907,"accession":"0001253936-04-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253936-04-000002","line_url":"/filing/0001253936-04-000002#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR INC","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.32,"price_display":"2.32","price_state":"stated","total_value":11600.0,"total_display":"11,600.00","total_whole":"11,600","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-27","filed_date":"2004-05-27","scope":"insider"},{"id":529653,"accession":"0001253936-04-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253936-04-000001","line_url":"/filing/0001253936-04-000001#line-1","is_derivative":false,"issuer_cik":"0000934936","issuer_name":"SCOLR INC","issuer_ticker":"DDD","issuer_name_source":null,"issuer_url":"/issuer/0000934936","owner_cik":"0001253936","owner_name":"WILDS DANIEL O","owner_display_name":"WILDS DANIEL O","owner_url":"/insider/0001253936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":8750.0,"total_display":"8,750.00","total_whole":"8,750","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-25","filed_date":"2004-05-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":48,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000934936","name":"SCOLR Pharma, Inc.","url":"/issuer/0000934936","role":"Director, Officer (Chief Executive Officer)","n_filings":19,"first_seen":"2004-05-25","last_seen":"2008-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001253936","retrieved_at":"2026-08-25T07:30:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}